Literature DB >> 153933

Differential cyclophosphamide sensitivity of precursor cells in allogeneic and H-2 restricted cytotoxic responses.

M Hurme.   

Abstract

Spleen cells from cyclophosphamide-treated mice responded in vitro to allogeneic stimulator cells but not to TNP-coupled syngeneic spleen cells. Similarly, cells from female mice, primed in vivo with syngeneic male cells, could not respond in vitro to male spleen cell stimulation if the mice were pretreated with cyclophosphamide. These results suggest that the precursor cells for H-2-restricted cytotoxic responses belong to a different T-cell subpopulation than the precursor cells for allogeneic responses.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 153933      PMCID: PMC2184736          DOI: 10.1084/jem.149.1.290

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  Micromethods for induction and assay of mouse mixed lymphocyte reactions and cytotoxicity.

Authors:  E Simpson; R Gordon; M Taylor; J Mertin; P Chandler
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

2.  Induction of autoreactive T lymphocytes and their suppressor cells by cyclophosphamide.

Authors:  J L'age-Stehr; T Diamanstein
Journal:  Nature       Date:  1978-02-16       Impact factor: 49.962

3.  Regulation of cellular and humoral immune responses by T-cell subclasses.

Authors:  H Cantor; E A Boyse
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

4.  Differential effects of cyclophosphamide on the B and T cell compartments of adult mice.

Authors:  G D Stockman; L R Heim; M A South; J J Trentin
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

5.  Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.

Authors:  H K Gill; F Y Liew
Journal:  Eur J Immunol       Date:  1978-03       Impact factor: 5.532

6.  Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors.

Authors:  K F Lindahl; D B Wilson
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

7.  In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice.

Authors:  R D Gordon; E Simpson; L E Samelson
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

8.  Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid50-L-tyrosine50 induced in BALB/c mice by cyclophosphamide.

Authors:  P Debré; C Waltenbaugh; M E Dorf; B Benacerraf
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

9.  Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.

Authors:  P W Askenase; B J Hayden; R K Gershon
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

10.  Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.

Authors:  M Röllinghoff; A Starzinski-Powitz; K Pfizenmaier; H Wagner
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

View more
  8 in total

1.  Immunotoxicity of immunotherapeutic agents.

Authors:  A G Johnson; J Regal
Journal:  Springer Semin Immunopathol       Date:  1985

2.  Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the host.

Authors:  K Ryoyama; C Ryoyama
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity.

Authors:  S K Hoover; S K Barrett; T M Turk; T C Lee; H D Bear
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

4.  Rescue of anti-influenza A virus cytotoxic T-lymphocyte responses in chemotherapy-suppressed mice.

Authors:  V J Merluzzi; K Welte; R H Mertelsmann; L Souza; T Boone; K Last-Barney
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

5.  The effects of cyclophosphamide on in vitro cytotoxic responses to a syngeneic tumour.

Authors:  E J Hancock; D G Kilburn
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

6.  Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells.

Authors:  L P Zhu; T R Cupps; G Whalen; A S Fauci
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

7.  Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice.

Authors:  F Bistoni; M Baccarini; E Blasi; P Marconi; P Puccetti; E Garaci
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

8.  The effect of cyclophosphamide on cytotoxic T-lymphocyte responses: inhibition of helper T-cell induction in vitro.

Authors:  K Varkila; M Hurme
Journal:  Immunology       Date:  1983-03       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.